The wait for definitive results from Allogene Therapeutics’ pivotal clinical trial of ALLO-719, an off-the-shelf CAR-T cell therapy for large B-cell lymphoma, is nearing an end. … Read more
The No Surprises Act, a landmark federal law intended to shield patients from unexpected medical bills, is facing scrutiny as some allege it’s being exploited for … Read more
The Affordable Care Act (ACA) marketplace is seeing continued shifts as major players reassess their strategies. Aetna, a subsidiary of CVS Health, has ceased selling ACA … Read more
The landscape of cancer prevention is undergoing a subtle but significant shift, moving beyond lifestyle modifications and screenings toward the potential of preventive vaccines—not to *treat* … Read more
Helen Branswell covers issues broadly related to infectious diseases, including outbreaks, preparedness, research, and vaccine development. Follow her on Mastodon and Bluesky. You can reach Helen … Read more
Novartis Invests $23 Billion in US Expansion with New San Diego Research Hub Pharmaceutical giant Novartis has broken ground on a cutting-edge biomedical research center in … Read more
WASHINGTON – Food and Drug Governance leaders attempted to address growing concerns on Tuesday regarding a new program designed to accelerate the approval of certain drugs. … Read more
Johnson & Johnson reported fourth-quarter earnings that met expectations, with revenue slightly exceeding estimates. A significant health care bill moving through Congress aims too revive pharmacy … Read more